Gritz L[Author] - Search Results

Year	Number of Results
1978	1
1980	1
1982	1
1983	1
1985	2
1990	2
1991	2
1994	1
1995	2
1997	2
1998	1
1999	2
2000	3
2003	3
2004	1
2005	2
2006	1
2012	1
2013	1
2014	1
2024	0

1

Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus.

Jackson SS, Ilyinskii P, Philippon V, Gritz L, Yafal AG, Zinnack K, Beaudry KR, Manson KH, Lifton MA, Kuroda MJ, Letvin NL, Mazzara GP, Panicali DL. Jackson SS, et al. Among authors: gritz l. J Virol. 2005 May;79(10):6554-9. doi: 10.1128/JVI.79.10.6554-6559.2005. J Virol. 2005. PMID: 15858042 Free PMC article.

2

Generation of hybrid genes and proteins by vaccinia virus-mediated recombination: application to human immunodeficiency virus type 1 env.

Gritz L, Destree A, Cormier N, Day E, Stallard V, Caiazzo T, Mazzara G, Panicali D. Gritz L, et al. J Virol. 1990 Dec;64(12):5948-57. doi: 10.1128/JVI.64.12.5948-5957.1990. J Virol. 1990. PMID: 2243381 Free PMC article.

3

Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanoma.

Lindsey KR, Gritz L, Sherry R, Abati A, Fetsch PA, Goldfeder LC, Gonzales MI, Zinnack KA, Rogers-Freezer L, Haworth L, Mavroukakis SA, White DE, Steinberg SM, Restifo NP, Panicali DL, Rosenberg SA, Topalian SL. Lindsey KR, et al. Among authors: gritz l. Clin Cancer Res. 2006 Apr 15;12(8):2526-37. doi: 10.1158/1078-0432.CCR-05-2061. Clin Cancer Res. 2006. PMID: 16638862 Free PMC article. Clinical Trial.

4

Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen.

Wang M, Bronte V, Chen PW, Gritz L, Panicali D, Rosenberg SA, Restifo NP. Wang M, et al. Among authors: gritz l. J Immunol. 1995 May 1;154(9):4685-92. J Immunol. 1995. PMID: 7722321 Free PMC article.

5

Identification of multiple simian immunodeficiency virus (SIV)-specific CTL epitopes in sooty mangabeys with natural and experimentally acquired SIV infection.

Kaur A, Yang J, Hempel D, Gritz L, Mazzara GP, McClure H, Johnson RP. Kaur A, et al. Among authors: gritz l. J Immunol. 2000 Jan 15;164(2):934-43. doi: 10.4049/jimmunol.164.2.934. J Immunol. 2000. PMID: 10623842

6

Enhanced activation of T cells by dendritic cells engineered to hyperexpress a triad of costimulatory molecules.

Hodge JW, Rad AN, Grosenbach DW, Sabzevari H, Yafal AG, Gritz L, Schlom J. Hodge JW, et al. Among authors: gritz l. J Natl Cancer Inst. 2000 Aug 2;92(15):1228-39. doi: 10.1093/jnci/92.15.1228. J Natl Cancer Inst. 2000. PMID: 10922408

7

Gender differences in human immunodeficiency virus type 1-specific CD8 responses in the reproductive tract and colon following nasal peptide priming and modified vaccinia virus Ankara boosting.

Peacock JW, Nordone SK, Jackson SS, Liao HX, Letvin NL, Yafal AG, Gritz L, Mazzara GP, Haynes BF, Staats HF. Peacock JW, et al. Among authors: gritz l. J Virol. 2004 Dec;78(23):13163-72. doi: 10.1128/JVI.78.23.13163-13172.2004. J Virol. 2004. PMID: 15542668 Free PMC article.

8

A recombinant vector expressing transgenes for four T-cell costimulatory molecules (OX40L, B7-1, ICAM-1, LFA-3) induces sustained CD4+ and CD8+ T-cell activation, protection from apoptosis, and enhanced cytokine production.

Grosenbach DW, Schlom J, Gritz L, Gómez Yafal A, Hodge JW. Grosenbach DW, et al. Among authors: gritz l. Cell Immunol. 2003 Mar;222(1):45-57. doi: 10.1016/s0008-8749(03)00080-7. Cell Immunol. 2003. PMID: 12798307

9

Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma.

Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Topalian SL, Sherry RM, Restifo NP, Wunderlich JR, Seipp CA, Rogers-Freezer L, Morton KE, Mavroukakis SA, Gritz L, Panicali DL, White DE. Rosenberg SA, et al. Among authors: gritz l. Clin Cancer Res. 2003 Aug 1;9(8):2973-80. Clin Cancer Res. 2003. PMID: 12912944 Free PMC article. Clinical Trial.

10

Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC1 gene and the murine T-cell costimulatory molecule B7.

Akagi J, Hodge JW, McLaughlin JP, Gritz L, Mazzara G, Kufe D, Schlom J, Kantor JA. Akagi J, et al. Among authors: gritz l. J Immunother. 1997 Jan;20(1):38-47. doi: 10.1097/00002371-199701000-00004. J Immunother. 1997. PMID: 9101412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

30 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year